Violation Tracker Summary for Mega-Scandal

Mega-Scandal: Generic Drug Pay for Delay
Description: This list shows cases in which drug companies paid penalties of $25 million or more for engaging in improper schemes to delay the introduction of lower-cost generic alternatives to prescription drugs whose patent protection was expiring.
Penalty Total since 2000: $8,791,475,000
Number of Penalty Records: 72
Note: The totals here are adjusted to account for the fact that each current parent's entries may include both agency records and settlement announcements for the same case; or else a penalty covering multiple locations may be listed in the individual records for each of the facilities. They are also adjusted to reflect cases in which federal and state or local agencies cooperated and issued separate announcements of the outcome. Duplicate or overlapping penalty amounts are marked with an asterisk in the individual records list below.